146 related articles for article (PubMed ID: 7592937)
1. Different antifolate-resistant L1210 cell variants with either increased or decreased folylpolyglutamate synthetase gene expression at the level of mRNA transcription.
Roy K; Mitsugi K; Sirlin S; Shane B; Sirotnak FM
J Biol Chem; 1995 Nov; 270(45):26918-22. PubMed ID: 7592937
[TBL] [Abstract][Full Text] [Related]
2. Posttranscriptionally mediated decreases in folylpolyglutamate synthetase gene expression in some folate analogue-resistant variants of the L1210 cell. Evidence for an altered cognate mRNA in the variants affecting the rate of de novo synthesis of the enzyme.
Roy K; Egan MG; Sirlin S; Sirotnak FM
J Biol Chem; 1997 Mar; 272(11):6903-8. PubMed ID: 9054377
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter.
Roy K; Chiao JH; Spengler BA; Tolner B; Yang CH; Biedler JL; Sirotnak FM
Cancer Genet Cytogenet; 1998 Aug; 105(1):29-38. PubMed ID: 9689927
[TBL] [Abstract][Full Text] [Related]
4. Rapid decline in folylpolyglutamate synthetase activity and gene expression during maturation of HL-60 cells. Nature of the effect, impact on folate compound polyglutamate pools, and evidence for programmed down-regulation during maturation.
Egan MG; Sirlin S; Rumberger BG; Garrow TA; Shane B; Sirotnak FM
J Biol Chem; 1995 Mar; 270(10):5462-8. PubMed ID: 7890662
[TBL] [Abstract][Full Text] [Related]
5. Preferential selection during therapy in vivo by edatrexate compared to methotrexate of resistant L1210 cell variants with decreased folylpolyglutamate synthetase activity.
Rumberger BG; Schmid FA; Otter GM; Sirotnak FM
Cancer Commun; 1990; 2(9):305-10. PubMed ID: 2206778
[TBL] [Abstract][Full Text] [Related]
6. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
[TBL] [Abstract][Full Text] [Related]
7. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling.
Yang CH; Sirotnak FM; Mines LS
J Biol Chem; 1988 Jul; 263(20):9703-9. PubMed ID: 2838477
[TBL] [Abstract][Full Text] [Related]
8. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
[TBL] [Abstract][Full Text] [Related]
9. Variable expression of the folylpolyglutamate synthetase gene at the level of mRNA transcription in human leukemia cell lines sensitive, or made resistant, to various antifolate drugs.
Takemura Y; Kobayashi H; Miyachi H
Anticancer Drugs; 1999 Aug; 10(7):677-83. PubMed ID: 10507318
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of the reduced folate carrier and folypolyglutamate synthetase is the basis for acquired resistance to the pemetrexed antifolate (LY231514) in an L1210 murine leukemia cell line.
Wang Y; Zhao R; Goldman ID
Biochem Pharmacol; 2003 Apr; 65(7):1163-70. PubMed ID: 12663051
[TBL] [Abstract][Full Text] [Related]
11. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
McGuire JJ; Russell CA
Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of murine leukemia cell lines resistant to 5, 10-dideazatetrahydrofolate identifies several amino acids critical to the function of folylpolyglutamate synthetase.
Zhao R; Titus S; Gao F; Moran RG; Goldman ID
J Biol Chem; 2000 Aug; 275(34):26599-606. PubMed ID: 10856298
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
14. Folylpoly-gamma-glutamate synthetase: generation of isozymes and the role in one carbon metabolism and antifolate cytotoxicity.
Qi H; Atkinson I; Xiao S; Choi YJ; Tobimatsu T; Shane B
Adv Enzyme Regul; 1999; 39():263-73. PubMed ID: 10470377
[TBL] [Abstract][Full Text] [Related]
15. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
[TBL] [Abstract][Full Text] [Related]
16. Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia.
Stark M; Wichman C; Avivi I; Assaraf YG
Blood; 2009 Apr; 113(18):4362-9. PubMed ID: 19131550
[TBL] [Abstract][Full Text] [Related]
17. Organization and alternate splicing of the murine folylpolyglutamate synthetase gene. Different splice variants in L1210 cells encode mitochondrial or cytosolic forms of the enzyme.
Roy K; Mitsugi K; Sirotnak FM
J Biol Chem; 1996 Sep; 271(39):23820-7. PubMed ID: 8798611
[TBL] [Abstract][Full Text] [Related]
18. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action.
Rumberger BG; Barrueco JR; Sirotnak FM
Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of histidine analogues of folic acid and methotrexate as potential folylpolyglutamate synthetase inhibitors.
Mao Z; Pan J; Kalman TI
J Med Chem; 1996 Oct; 39(21):4340-4. PubMed ID: 8863812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
